Cyrus Desouza

10.3k total citations · 1 hit paper
108 papers, 2.8k citations indexed

About

Cyrus Desouza is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Cyrus Desouza has authored 108 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Endocrinology, Diabetes and Metabolism, 33 papers in Molecular Biology and 25 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Cyrus Desouza's work include Diabetes Treatment and Management (35 papers), Diabetes Management and Research (27 papers) and Metabolism, Diabetes, and Cancer (20 papers). Cyrus Desouza is often cited by papers focused on Diabetes Treatment and Management (35 papers), Diabetes Management and Research (27 papers) and Metabolism, Diabetes, and Cancer (20 papers). Cyrus Desouza collaborates with scholars based in United States, Denmark and United Kingdom. Cyrus Desouza's co-authors include Vivian Fonseca, Geremia B. Bolli, Joseph P. Murgo, Benjamin Cheong, Dennis B. McNamara, Viswanathan Saraswathi, Aditi Parulkar, Donald L. Akers, Mary Keebler and Vijay Shivaswamy and has published in prestigious journals such as New England Journal of Medicine, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

Cyrus Desouza

101 papers receiving 2.7k citations

Hit Papers

Once-Weekly Insulin Icodec vs Once-Daily Insulin Degludec... 2023 2026 2024 2025 2023 25 50 75
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Once-Weekly Insulin Icodec vs Once-Daily Insulin Degludec in Adults With Insulin-Naive Type 2 Diabetes
    2023 84 citations Cyrus Desouza, Pierre Gourdy et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cyrus Desouza United States 29 1.3k 636 450 449 440 108 2.8k
Zubin Punthakee Canada 24 1.2k 0.9× 484 0.8× 363 0.8× 921 2.1× 433 1.0× 75 3.1k
Hong Chen China 27 952 0.7× 843 1.3× 344 0.8× 678 1.5× 236 0.5× 127 2.9k
Leena Moilanen Finland 27 940 0.7× 294 0.5× 514 1.1× 536 1.2× 578 1.3× 67 2.5k
Markus Laimer Switzerland 30 796 0.6× 279 0.4× 564 1.3× 634 1.4× 429 1.0× 87 2.3k
Jinping Wang China 19 1.6k 1.2× 725 1.1× 453 1.0× 1.1k 2.4× 394 0.9× 96 3.8k
Jürgen Harreiter Austria 22 1.3k 1.0× 420 0.7× 631 1.4× 514 1.1× 395 0.9× 80 3.4k
Vincent Rigalleau France 35 1.3k 1.0× 352 0.6× 540 1.2× 708 1.6× 425 1.0× 164 3.6k
Stella Trompet Netherlands 34 741 0.6× 589 0.9× 816 1.8× 602 1.3× 784 1.8× 149 3.7k
Maria Svensson Sweden 33 1.6k 1.2× 967 1.5× 919 2.0× 817 1.8× 590 1.3× 114 3.8k
Dee Pei Taiwan 28 1.2k 0.9× 788 1.2× 389 0.9× 493 1.1× 448 1.0× 137 2.8k

Countries citing papers authored by Cyrus Desouza

Since Specialization
Citations

This map shows the geographic impact of Cyrus Desouza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cyrus Desouza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cyrus Desouza more than expected).

Fields of papers citing papers by Cyrus Desouza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cyrus Desouza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cyrus Desouza. The network helps show where Cyrus Desouza may publish in the future.

Co-authorship network of co-authors of Cyrus Desouza

This figure shows the co-authorship network connecting the top 25 collaborators of Cyrus Desouza. A scholar is included among the top collaborators of Cyrus Desouza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cyrus Desouza. Cyrus Desouza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Letourneau, Lisa R., Rochelle N. Naylor, Siri Atma W. Greeley, et al.. (2025). Advancing Monogenic Diabetes Research and Clinical Care by Creating a Data Commons: The Precision Diabetes Consortium (PREDICT). Journal of Diabetes Science and Technology. 570920112–570920112.
2.
Eiland, Leslie, et al.. (2024). Diabetes On Track: Redesigning Diabetes Management in Rural Primary Care. Diabetes Spectrum. 38(2). 145–152. 1 indexed citations
3.
4.
5.
Corbin, Karen D., Anastassios G. Pittas, Cyrus Desouza, et al.. (2023). Indices of hepatic steatosis and fibrosis in prediabetes and association with diabetes development in the vitamin D and type 2 diabetes study. Journal of Diabetes and its Complications. 37(6). 108475–108475. 7 indexed citations
6.
Kashyap, Sangeeta R., Cyrus Desouza, Vanita R. Aroda, et al.. (2023). Glycemic and metabolic sub-classification of prediabetes and risk factors for cardiovascular disease in the D2d cohort. SHILAP Revista de lepidopterología. 15. 100525–100525. 4 indexed citations
7.
Desouza, Cyrus, Ranee Chatterjee, Ellen M. Vickery, et al.. (2022). The effect of vitamin D supplementation on cardiovascular risk in patients with prediabetes: A secondary analysis of the D2d study. Journal of Diabetes and its Complications. 36(8). 108230–108230. 14 indexed citations
8.
Saraswathi, Viswanathan, et al.. (2022). Myristic Acid Supplementation Aggravates High Fat Diet-Induced Adipose Inflammation and Systemic Insulin Resistance in Mice. Biomolecules. 12(6). 739–739. 27 indexed citations
9.
Mosenzon, Ofri, Signe Rosenlund, Jan W. Eriksson, et al.. (2019). 1004-P: Oral Semaglutide vs. Placebo in Patients with Type 2 Diabetes and Moderate Renal Impairment: PIONEER 5. Diabetes. 68(Supplement_1). 8 indexed citations
10.
Desouza, Cyrus, Richard Holcomb, Julio Rosenstock, et al.. (2019). Results of a Study Comparing Glycated Albumin to Other Glycemic Indices. The Journal of Clinical Endocrinology & Metabolism. 105(3). 677–687. 25 indexed citations
11.
Embury, Christine M., Timothy J. McDermott, Alex I. Wiesman, et al.. (2018). Altered Neural Dynamics during a Flanker Attention Task in Patients with Type 1 Diabetes. Diabetes. 67(Supplement_1). 1 indexed citations
12.
Befort, Christie A., Jeffrey J. VanWormer, Cyrus Desouza, et al.. (2016). Protocol for the Rural Engagement in Primary Care for Optimizing Weight Reduction (RE-POWER) Trial: Comparing three obesity treatment models in rural primary care. Contemporary Clinical Trials. 47. 304–314. 21 indexed citations
13.
Saraswathi, Viswanathan, et al.. (2015). Ablation of COX‐2 Attenuates Adipose Inflammation but Impairs Metabolic Homeostasis in Diet‐induced Obesity. The FASEB Journal. 29(S1). 1 indexed citations
14.
Goldfine, Allison B., Jackie Buck, Cyrus Desouza, et al.. (2013). Targeting Inflammation Using Salsalate in Patients With Type 2 Diabetes: Effects on Flow-Mediated Dilation (TINSAL-FMD). Diabetes Care. 36(12). 4132–4139. 37 indexed citations
15.
Eiland, Leslie, Whitney Goldner, Andjela Drincic, & Cyrus Desouza. (2013). Inpatient Hypoglycemia: A Challenge That Must Be Addressed. Current Diabetes Reports. 14(1). 445–445. 17 indexed citations
16.
Shao, Chun Hong, Kaushik P. Patel, Mu Wang, et al.. (2011). Carbonylation Contributes to SERCA2a Activity Loss and Diastolic Dysfunction in a Rat Model of Type 1 Diabetes. Diabetes. 60(3). 947–959. 76 indexed citations
17.
Desouza, Cyrus, et al.. (2006). Long-term effects of a PPAR-gamma agonist, pioglitazone, on neointimal hyperplasia and endothelial regrowth in insulin resistant rats. Vascular Pharmacology. 46(3). 188–194. 14 indexed citations
18.
19.
Desouza, Cyrus, Mary Keebler, Dennis B. McNamara, & Vivian Fonseca. (2002). Drugs Affecting Homocysteine Metabolism. Drugs. 62(4). 605–616. 104 indexed citations
20.
Desouza, Cyrus, et al.. (2002). Effects of the Thiazolidinediones on Cardiovascular Risk Factors. American Journal of Cardiovascular Drugs. 2(3). 149–156. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zubin Punthakee Breakdown of academic impact, for papers by Hong Chen Breakdown of academic impact, for papers by Leena Moilanen Breakdown of academic impact, for papers by Markus Laimer Breakdown of academic impact, for papers by Jinping Wang Breakdown of academic impact, for papers by Jürgen Harreiter Breakdown of academic impact, for papers by Vincent Rigalleau Breakdown of academic impact, for papers by Stella Trompet Breakdown of academic impact, for papers by Maria Svensson Breakdown of academic impact, for papers by Dee Pei
Rankless by CCL
2026